ConductScience.org, home

Paper6602018

Decreased TCGF activity in the culture medium of PHA stimulated peripheral mononuclear cells from patients with metastatic cancer.

Nakayama E and 4 others. Clin Exp Immunol, 1983. Cited by 45 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Decreased TCGF activity in the culture medium of PHA stimulated peripheral mononuclear cells from patients with metastatic cancer. Papers, record 6602018. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6602018

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Decreased TCGF activity in the culture medium of PHA stimulated peripheral mononuclear cells from patients with metastatic cancer.
PubMed
Journal
Clin Exp Immunol
PubMed
Year
1983
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
45
iCite
Relative citation ratio, by iCite
1.47
iCite
Revised in PubMed
2018-11-13
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nakayama EE
2Asano SS
3Takuwa NN
4Yokota JJ
5Miwa SS

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Interleukin-2Major topic
LymphocytesMajor topic
NeoplasmsMajor topic
Cell Adhesion
Cells, Cultured
Female
Humans
Lymphocyte Activation
Male
Neoplasm Metastasis
Phytohemagglutinins
Time Factors

Source PubMed

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1181,845Selective in vitro growth of T lymphocytes from normal human bone marrows.Science1976https://conductscience.org/library/papers/181845PubMed
2301,122Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: the role of suppressor cells.Int J Cancer1977https://conductscience.org/library/papers/301122PubMed
3157,374Human T cell growth factor. I. Optimal conditions for its production.J Immunol1979https://conductscience.org/library/papers/157374PubMed
46,255,556TCGF production for cloning and growth of functional human T lymphocytes.Scand J Immunol1980https://conductscience.org/library/papers/6255556PubMed
56,453,654Adherent cells (macrophages?) in tumor-bearing mice suppress MLC responses.Cell Immunol1981https://conductscience.org/library/papers/6453654PubMed
67,039,892Depressed immunity and the development of cancer.Clin Exp Immunol1981https://conductscience.org/library/papers/7039892PubMed
76,454,723Regulation of T cell growth factor production: arrest of TCGF production after 18 hours in normal lectin-stimulated mouse spleen cell cultures.J Immunol1981https://conductscience.org/library/papers/6454723PubMed
86,265,681Colonies formed in agar from human breast cancer and their identification as T-lymphocytes.J Natl Cancer Inst1981https://conductscience.org/library/papers/6265681PubMed
96,974,135Colony formation by T-lymphocytes infiltrating human tumours.Immunol Lett1981https://conductscience.org/library/papers/6974135PubMed
106,977,616Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.J Exp Med1982https://conductscience.org/library/papers/6977616PubMed
117,019,041Interleukin-2 dependent culture of cytolytic T cell lines.Immunol Rev1981https://conductscience.org/library/papers/7019041PubMed

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.

PMIDTitleJournalYearIn PapersSource
8,347,492Interleukin-2 receptor and ovarian cancer.Br J Cancer1993https://conductscience.org/library/papers/8347492PubMed
6,334,769Immunodepression after surgery: impaired production of interleukin 2.Jpn J Surg1984https://conductscience.org/library/papers/6334769PubMed
3,871,677Impaired production of interleukin-2 after surgery.Clin Exp Immunol1985https://conductscience.org/library/papers/3871677PubMed
3,486,732Interleukin 2 activity in chronic liver disease and the effect of in vitro alpha-interferon.Clin Exp Immunol1986https://conductscience.org/library/papers/3486732PubMed
3,265,969Decreased interleukin generation in patients with cancer of the digestive system. A correlation between interleukin 1 and interleukin 2 production.Jpn J Surg1988https://conductscience.org/library/papers/3265969PubMed
2,245,177Serum interleukin-2 levels in relation to the neuroendocrine status in cancer patients.Br J Cancer1990https://conductscience.org/library/papers/2245177PubMed
1,972,685Interleukin 2 and interferon-gamma activities of mononuclear cells from regional lymph nodes in patients with gastric cancer.Gastroenterol Jpn1990https://conductscience.org/library/papers/1972685PubMed

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IL23,558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
LBR3,930PubTator's text mininghttps://conductscience.org/library/genes/3930NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6602018

GET https://conductscience.org/api/papers/v1/6602018/authors